Related references
Note: Only part of the references are listed.Can In Vitro-In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions
Leslie Z. Benet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space
Felix Huth et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
K. Sandy Pang et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Using Membrane Partitioning Simulations To Predict Permeability of Forty-Nine Drug-Like Molecules
Callum J. Dickson et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
Julia Riede et al.
DRUG METABOLISM AND DISPOSITION (2017)
New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data
Julia Riede et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans
Tomomi Taniguchi-Takizawa et al.
DRUG METABOLISM AND PHARMACOKINETICS (2015)
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Manthena V. Varma et al.
PHARMACEUTICAL RESEARCH (2015)
Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo
Haifeng Zhang et al.
SCIENTIFIC REPORTS (2015)
Permeability Comparison between Hepatocyte and Low Efflux MDCKII Cell Monolayer
Rui Li et al.
AAPS JOURNAL (2014)
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development
Leslie Z. Benet
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions
Olena Kis et al.
PHARMACEUTICAL RESEARCH (2013)
Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement
Ken Grime et al.
DRUG METABOLISM AND DISPOSITION (2013)
Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions
Gian Camenisch et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial
M. J. McKeage et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
Li Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery
Manthena V. Varma et al.
MOLECULAR PHARMACEUTICS (2012)
Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
Ken-ichi Umehara et al.
PHARMACEUTICAL RESEARCH (2012)
Pitavastatin: An overview
Yasushi Saito
ATHEROSCLEROSIS SUPPLEMENTS (2011)
Patupilone in cancer treatment
Branislav Bystricky et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Predicting Drug Disposition via Application of a Biopharmaceutics Drug Disposition Classification System
Leslie Z. Benet
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences
Deepak Dalvie et al.
DRUG METABOLISM AND DISPOSITION (2010)
Use of intrinsic clearance for prediction of human hepatic clearance
Piyun Chao et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase
Michael Zientek et al.
DRUG METABOLISM AND DISPOSITION (2010)
Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans
Handan He et al.
DRUG METABOLISM AND DISPOSITION (2009)
Hepatocellular binding of drugs: Correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data
Peter J. Kilford et al.
DRUG METABOLISM AND DISPOSITION (2008)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Cell culture-based models for intestinal permeability: a critique
PV Balimane et al.
DRUG DISCOVERY TODAY (2005)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects
JB Mangold et al.
DRUG METABOLISM AND DISPOSITION (2004)
Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio
E Rinaki et al.
PHARMACEUTICAL RESEARCH (2003)
The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
RP Austin et al.
DRUG METABOLISM AND DISPOSITION (2002)
Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction
H Stass et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke:: in vitro-in vivo correlations
RAHJ Gilissen et al.
XENOBIOTICA (2000)
Clinical pharmacology of gatifloxacin, a new fluoroquinolone
DM Grasela
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
